<DrugInformationSummary id="CDR0000735473"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Pertuzumab works by binding to HER2, a protein found in high levels on some cancer cells and causes them to grow. The binding of pertuzumab to HER2 blocks these signals, causing the cells to stop growing and die. Pertuzumab also triggers a type of immune reaction that kills cells that have a lot of HER2. It is a type of targeted therapy drug called a monoclonal antibody.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/pertuzumab">Pertuzumab</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000322808">pertuzumab</TerminologyLink><GlossaryLink ref="CDR0000340934">pertuzumab</GlossaryLink><USBrandNames><USBrandName>Perjeta</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>per-TOO-zoo-mab</TermPronunciation><MediaLink ref="CDR0000711657" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000711656" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Pertuzumab</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f85d17-ab71-4f5b-9fe3-0b8c822f69ff&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Pertuzumab
         is approved 
         to be used with <GlossaryTermRef href="CDR0000045439" dictionary="Cancer.gov" audience="Patient">trastuzumab</GlossaryTermRef> and either <GlossaryTermRef href="CDR0000045382" dictionary="Cancer.gov" audience="Patient">docetaxel</GlossaryTermRef> or other drugs to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef></Strong> that is <GlossaryTermRef href="CDR0000737998" dictionary="Cancer.gov" audience="Patient">HER2 positive</GlossaryTermRef> (HER2+). It is used:<ItemizedList Style="bullet" id="_5"><ListItem>in patients with <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef> disease that has  not been treated with anti-HER2 therapy or chemotherapy for metastatic cancer</ListItem><ListItem>as <GlossaryTermRef href="CDR0000045800" dictionary="Cancer.gov" audience="Patient">neoadjuvant therapy</GlossaryTermRef> (to shrink the tumor before surgery) in patients with <GlossaryTermRef href="CDR0000045955" dictionary="Cancer.gov" audience="Patient">locally advanced</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045313" dictionary="Cancer.gov" audience="Patient">inflammatory</GlossaryTermRef>, or <GlossaryTermRef href="CDR0000446564" dictionary="Cancer.gov" audience="Patient">early stage</GlossaryTermRef> breast cancer</ListItem><ListItem>as <GlossaryTermRef href="CDR0000045587" dictionary="Cancer.gov" audience="Patient">adjuvant therapy</GlossaryTermRef> in patients with early stage breast cancer who have a high risk that the cancer will come back</ListItem></ItemizedList></ListItem>
   
   </ItemizedList>
  <Para id="_6">Pertuzumab is also available in a different form, combined with <GlossaryTermRef href="CDR0000045439" dictionary="Cancer.gov" audience="Patient">trastuzumab</GlossaryTermRef> and  <GlossaryTermRef href="CDR0000791166" dictionary="Cancer.gov" audience="Patient">hyaluronidase</GlossaryTermRef>. For more information, see the Drug Information Summary for <DrugRef href="CDR0000801930" url="/about-cancer/treatment/drugs/pertuzumabtrastuzumabandhyaluronidase-zzxf">Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf</DrugRef>.</Para><Para id="_4">Pertuzumab
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Pertuzumab</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/322808">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.28">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a612027.html">Pertuzumab</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.29"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.30">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C38692">Find Clinical Trials for Pertuzumab</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2012-07-13</DateFirstPublished><DateLastModified>2024-12-20</DateLastModified></DrugInformationSummary>
